![Roy Prieb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Roy Prieb
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Kleo Pharmaceuticals, Inc.
![]() Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Roy Prieb
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Yale University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Founder | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Apterna Ltd. | Director/Board Member | ||
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Ottawa | College/University | Doctorate Degree | |
Tizona Therapeutics, Inc.
![]() Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Founder | |
Potenza Therapeutics, Inc.
![]() Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Corporate Officer/Principal | |
The University of Colorado | College/University | Doctorate Degree | |
BYOMass, Inc.
![]() BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services BYOMass, Inc. provides investment holding services. The company is headquartered in Sudbury, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Mediqventures Ltd.
![]() Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance/Rental/Leasing | Corporate Officer/Principal | |
ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Causeway Therapeutics Ltd.
![]() Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | Pharmaceuticals: Major | Chairman | |
TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Kent | College/University | Doctorate Degree | |
University of Glasgow School of Medicine | College/University | Corporate Officer/Principal | |
Kitasato University | College/University | Corporate Officer/Principal | |
Harvard T.H. Chan School of Public Health | College/University | Corporate Officer/Principal | |
Juvenescence Ltd.
![]() Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Founder | |
iOX Therapeutics Ltd.
![]() iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
Lakewood-Amedex, Inc.
![]() Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL. | Pharmaceuticals: Major | Director/Board Member | |
Flare Therapeutics, Inc.
![]() Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer | |
Heptares Therapeutics Ltd.
![]() Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Fred Hutchinson Cancer Research Center
![]() Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | President | |
MYREXIS, INC. | Financial Conglomerates | Corporate Officer/Principal | |
Nuview Life Sciences, Inc.
![]() Nuview Life Sciences, Inc. Medical/Nursing ServicesHealth Services Nuview Life Sciences, Inc. is a clinical stage oncology company, which engages in the provision of precision cancer diagnostics and theranostics services. The company was founded by Paul J. Crowe in 2005 and is headquartered in Park City, UT. | Medical/Nursing Services | Corporate Officer/Principal | |
Simpson Healthcare Executives LLC | Corporate Officer/Principal | ||
Biohaven Pharmaceuticals, Inc.
![]() Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Connecticut Innovations, Inc.
![]() Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Investment Managers | Private Equity Investor | |
Fred Hutchinson Cancer Center
![]() Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Fred Hutchinson Cancer Center is a research and patient care institution that is committed to eradicating cancer and related diseases as causes of human suffering and death. The center conducts research and provides patient care of the highest standards to improve the prevention and treatment of cancer and related diseases. | Hospital/Nursing Management | President | |
FOGHORN THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
Hummingbird Bioscience Pte Ltd.
![]() Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
Seattle Cancer Care Alliance
![]() Seattle Cancer Care Alliance Hospital/Nursing ManagementHealth Services Part of Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance is a leading research and healthcare organization dedicated to improving the lives of cancer patients. Seattle Cancer Care Alliance brings together top research teams and cancer specialists from Fred Hutch, Seattle Children's, and UW Medicine. Based in Seattle, WA, Seattle Cancer Care Alliance has nine clinical care sites in the region, including medical oncology clinics, hematology/medical oncology and infusion services, and radiation oncology clinics. Seattle Cancer Care Alliance was acquired by Fred Hutchinson Cancer Research Center on April 01, 2022. The company also has network affiliations with hospitals in five states. Founded in 1998, the company is committed to the pursuit of better, longer, and richer lives for their patients. | Hospital/Nursing Management | Director/Board Member | |
Yale School of Medicine | College/University | Corporate Officer/Principal | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The General Hospital Corp.
![]() The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Massachusetts General Hospital Cancer Center
![]() Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member | |
Massachusetts General Physician's Organization, Inc.
![]() Massachusetts General Physician's Organization, Inc. Medical/Nursing ServicesHealth Services Massachusetts General Physician's Organization, Inc. operates as a multi-specialty medical firm. It is working in partnership with the Massachusetts General Hospital and in cooperation with Partners HealthCare to builds on the synergies among clinical practice, research and teaching to improve its patient's well being and the professional lives of physicians and staff. The company is headquartered in Boston, MA. | Medical/Nursing Services | Chief Executive Officer | |
PearlPoint Cancer Support, Inc.
![]() PearlPoint Cancer Support, Inc. Miscellaneous Commercial ServicesCommercial Services PearlPoint Cancer Support, Inc. offers guidance and compassionate support to any adult impacted by cancer. It also offers ancer library, information about clinical trials information, side effects management & nutrition consultations with registered dietitians, and access to our cancer supportive services. The company was founded by Thomas Frist and Steven Stroup in 1987 and is headquartered in Nashville, TN. | Miscellaneous Commercial Services | Director/Board Member | |
International Association for the Study of Lung Cancer | Corporate Officer/Principal | ||
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Association for Cancer Research
![]() American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Schwartz Center for Compassionate Healthcare | Director/Board Member | ||
Harvard Medical School | College/University | Corporate Officer/Principal | |
Yale Cancer Center
![]() Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Director/Board Member | |
INTENSITY THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 38 |
Vereinigtes Königreich | 10 |
Kanada | 2 |
Japan | 2 |
Singapur | 2 |
Sektoral
Health Technology | 19 |
Consumer Services | 11 |
Health Services | 9 |
Commercial Services | 7 |
Finance | 5 |
Operativ
Director/Board Member | 55 |
Corporate Officer/Principal | 29 |
Chairman | 17 |
Independent Dir/Board Member | 10 |
Chief Tech/Sci/R&D Officer | 10 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
John Childs | 40 |
Declan Doogan | 28 |
Thomas Lynch | 20 |
Brian Dowd | 9 |
Douglas Manion | 8 |
Charles G. Drake | 6 |
David Spiegel | 1 |
Christopher Eklund | 1 |